The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 118.00
Bid: 117.00
Ask: 119.00
Change: 1.00 (0.85%)
Spread: 2.00 (1.709%)
Open: 118.50
High: 118.50
Low: 118.00
Prev. Close: 117.00
XAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

2 Jun 2020 07:00

RNS Number : 5733O
Xaar PLC
02 June 2020
 

Xaar plc

 

Trading update 

 

 

At the Annual General Meeting ("AGM") held in Cambridge today, Andrew Herbert, Chairman of Xaar plc ("Xaar" or the "Group") will make the following statement:-

 

 

OPERATIONS

 

In responding to the challenges surrounding the COVID-19 pandemic, our priorities have been to safeguard the health and wellbeing of our colleagues, to maintain our business operations and to continue to serve our customers.

 

In March, when lockdown measures were introduced in the UK and elsewhere, we implemented safe working methods for all staff where their attendance on site was necessary, particularly in our factories, while other staff were able to work remotely. The whole team has demonstrated tremendous resilience in difficult circumstances and as a result the business has been able to operate efficiently and continue to meet its commitments to customers.

 

 

CURRENT TRADING AND OUTLOOK

 

Overall trading in the first four months of the new financial year has been in line with the expectation we established before the Covid-19 outbreak. Sales have been weaker in Europe and North America but stronger in Asia where economies have come out of lockdown sooner. Our short-term order book is healthy but the outlook for the second half of the year remains uncertain and it is too early to assess the impact of the pandemic on the results for the full year 2020 and into 2021.

 

The board will re-establish guidance on expectations as more economies emerge from lockdown and there is greater certainty surrounding economic conditions. We remain confident and focused on our medium-term strategy to return the business to profitability and growth.

 

 

BALANCE SHEET AND LIQUIDITY

 

The Group entered the year with a strong balance sheet and net cash and an appropriate level of funding to support its strategy. We have maintained disciplined cost control and strong cash management over the past four months and remain well positioned.

 

 

Enquiries:

 

Xaar plc

Ian Tichias, Chief Finance Officer

& Company Secretary

 

+44 (0) 1223 423 663 

John Mills, Chief Executive Officer

 

 

 

Tulchan Communications

 

 

 

+44 (0) 207 353 4200

James Macey White

Giles Kernick

Hollie Ralston

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLFLFBBQLZBBZ
Date   Source Headline
18th Mar 201612:07 pmRNSDirector/PDMR Shareholding
16th Mar 20167:00 amRNS2015 Full Year Results, 2020 Vision
7th Mar 201610:00 amRNSHolding(s) in Company
1st Mar 201610:13 amRNSTotal Voting Rights
1st Feb 20162:41 pmRNSTotal Voting Rights
22nd Jan 201612:02 pmRNSHolding(s) in Company
18th Jan 20166:16 pmRNSHolding(s) in Company
13th Jan 20167:00 amRNSScheduled Trading Statement
6th Jan 20167:00 amRNSXAAR STRENGTHENS ITS 3D PRINTING BUSINESS
4th Jan 20164:12 pmRNSBlocklisting Interim Review
4th Jan 20163:27 pmRNSTotal Voting Rights
17th Dec 201510:07 amRNSDirector Shareholding
11th Dec 20157:00 amRNSBoard Changes
9th Dec 20154:56 pmRNSHolding(s) in Company
1st Dec 20155:52 pmRNSTotal Voting Rights
25th Nov 20153:46 pmRNSHolding(s) in Company
16th Nov 20159:50 amRNSHolding(s) in Company
9th Nov 20151:53 pmRNSDirector/PDMR Shareholding
4th Nov 20157:00 amRNSInterim Management Statement
2nd Nov 20152:43 pmRNSTotal Voting Rights
7th Oct 20157:00 amRNSNotice of Trading Statement
1st Oct 201510:42 amRNSTotal Voting Rights
1st Sep 20152:43 pmRNSTotal Voting Rights
28th Aug 20153:44 pmRNSDirector Shareholding
27th Aug 20157:01 amRNS2015 Interim Results
26th Aug 20156:01 pmRNSHolding(s) in Company
3rd Aug 201510:25 amRNSTotal Voting Rights
8th Jul 20157:00 amRNSScheduled Trading Statement
7th Jul 20153:28 pmRNSHolding(s) in Company
1st Jul 20151:36 pmRNSBlocklisting Interim Review
1st Jul 20151:33 pmRNSTotal Voting Rights
5th Jun 20157:00 amRNSDirectorate Change
1st Jun 20151:16 pmRNSTotal Voting Rights
1st May 20151:27 pmRNSDirector Shareholding
1st May 201512:37 pmRNSTotal Voting Rights
27th Apr 201510:00 amRNSDirectorate Change
8th Apr 20153:58 pmRNSDirector/PDMR Shareholding
7th Apr 20154:33 pmRNSGrant of Options
7th Apr 20154:31 pmRNSDirector/PDMR Shareholding
31st Mar 20155:23 pmRNSTotal Voting Rights
27th Mar 201510:08 amRNSDirectorate Change
24th Mar 20152:15 pmRNSDirector/PDMR Shareholding
19th Mar 20157:00 amRNS2014 Full Year Results
3rd Mar 20159:51 amRNSTotal Voting Rights
2nd Mar 20157:00 amRNSDirector Appointment
16th Feb 20152:09 pmRNSDirectorate Change
2nd Feb 20155:52 pmRNSTotal Voting Rights
5th Jan 20157:00 amRNSAppointment of CEO
2nd Jan 201510:00 amRNSBlocklisting Interim Review
2nd Jan 201510:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.